RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @ATRIUMRx: Nice @JACCJournals review of beta blockers in the management of CVD. If you'd like to take a stroll through history, check ou…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @almucastro01: Revisión sobre la evidencia de la eficacia de los betabloqueantes en IC y enfermedad coronaria @JACCJournals https://t.co…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/Wl72aUfqCd
RT @almucastro01: Revisión sobre la evidencia de la eficacia de los betabloqueantes en IC y enfermedad coronaria @JACCJournals https://t.co…
RT @ATRIUMRx: Nice @JACCJournals review of beta blockers in the management of CVD. If you'd like to take a stroll through history, check ou…
RT @edurontoFF: The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/Pq4TvruYnG
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/hhgs7fdJbH
Revisión sobre la evidencia de la eficacia de los betabloqueantes en IC y enfermedad coronaria @JACCJournals https://t.co/gHKxEKaZKG https://t.co/gmzoRXkWDp
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @ATRIUMRx: Nice @JACCJournals review of beta blockers in the management of CVD. If you'd like to take a stroll through history, check ou…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @ATRIUMRx: Nice @JACCJournals review of beta blockers in the management of CVD. If you'd like to take a stroll through history, check ou…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
Nice @JACCJournals review of beta blockers in the management of CVD. If you'd like to take a stroll through history, check out our review on the use of beta blockers for ACS across the decades: https://t.co/UDxwyIiaZZ #CardioEd #MedEd
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
Great review series in the JACC Beta blockers; Philip Joseph, et al: https://t.co/xi9qGH0hXq ACEI/ARB ARNI; Darryl P. Leong, et al. https://t.co/HP14L8H04z Antithrombotics; Freek W.A. Verheugt, et al https://t.co/VSzOGv4NjP
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) | JACC: Journal of the American College of Cardiology https://t.co/ldBFWv4B9W
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
#JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's issue presents current evidence for β-blocker treatment as part of a focus seminar on pharmacological agents for CV care. https://t.co/
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/cRx1PvsRPv #importantconversations in #cardiology
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failu... https://t.co/tIFlzmgsZ9
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @edurontoFF: The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/Pq4TvruYnG
Excellent review in @JACCJournals on beta blockers in #heartfailure. Great series on medicines for #CVD https://t.co/TwQoCkrwdR
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
#JACC When is it appropriate to use β-blockers in heart failure and coronary heart disease patients? This State-of-the-Art Review presents current evidence for β-blocker treatment. https://t.co/m588gmjYEV
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @AlejandroLemor: Great #JACC review on The Evolution of β-Blockers in #CAD and #HF @waldarzi @elshabdel @AlexMichaelsMD @RyhmRadjef @S…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @edurontoFF: The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/Pq4TvruYnG
RT @AlejandroLemor: Great #JACC review on The Evolution of β-Blockers in #CAD and #HF @waldarzi @elshabdel @AlexMichaelsMD @RyhmRadjef @S…
RT @Derek_Leong_RPh: Great review of the evidence for use of beta blockers in HFrEF, HFpEF & HFmEF, ACS and stable CAD. https://t.co/ciSYwH…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
Great review of the evidence for use of beta blockers in HFrEF, HFpEF & HFmEF, ACS and stable CAD.
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
Great #JACC review on The Evolution of β-Blockers in #CAD and #HF @waldarzi @elshabdel @AlexMichaelsMD @RyhmRadjef @SaggerMawri @FerrasDabbagh1 @PedroMDMSc 📌https://t.co/DxO0084urs https://t.co/pEWlCb9H8H
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failu... https://t.co/tIFlzmgsZ9
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…